Not Tagged
natera
dr. adham jurdi, aka , is presenting during the on saturday, july 2. don't miss this satellite sympoisa on a tumor informed approach in the management of #gicancers. #wcgic2022 
Transforming the management of cancer with #Signatera, the personalized test for molecular residual disease detection and recurrence monitoring.